A Phase 1 Study of Picoplatin in Subjects With Advanced Non-Hematological Malignancies With Emphasis on Cardiac Repolarization.
Phase of Trial: Phase I
Latest Information Update: 21 Jul 2009
At a glance
- Drugs Picoplatin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 21 Jul 2009 Cardic safety data were reported in a Poniard Pharmaceuticals media release and will be presented at a medical conference later this year.
- 21 Jul 2009 Status changed from active, no longer recruiting to completed, according to a Poniard Pharmaceuticals media release.
- 17 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.